Filing Details
- Accession Number:
- 0001209191-20-055572
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-10-22 16:31:24
- Reporting Period:
- 2020-10-20
- Accepted Time:
- 2020-10-22 16:31:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1799448 | Aligos Therapeutics Inc. | ALGS | () | G7 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1388325 | A/S Holdings Novo | Tuborg Havnevej 19 Hellerup G7 2900 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-10-20 | 2,414,563 | $0.00 | 2,414,563 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2020-10-20 | 200,000 | $15.00 | 2,614,563 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | SERIES A CONVERTIBLE PREFERRED STOCK | Disposition | 2020-10-20 | 1,609,493 | $0.00 | 1,609,493 | $0.00 |
| Common Stock | SERIES B -1 CONVERTIBLE PREFERRED STOCK | Disposition | 2020-10-20 | 563,851 | $0.00 | 563,851 | $0.00 |
| Common Stock | SERIES B -2 CONVERTIBLE PREFERRED STOCK | Disposition | 2020-10-20 | 241,219 | $0.00 | 241,219 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- Each share of Series A Convertible Preferred Stock, Series B-1 Convertible Preferred Stock and Series B-2 Convertible Preferred Stock automatically converted into one share of common stock upon the closing of the Issuer's initial public offering. These shares have no expiration date.
- Represents a purchase from the underwriters in the Issuer's initial public offering.
Billionaire Hedge Funds
